Does Accutane Cause Hair Loss? Rates, Timeline and Regrowth
Does Accutane cause hair loss? Rates from the FDA label and a 2022 review, why shedding starts at month three, how long it lasts, and how fully it grows back.
The Short Answer
Does accutane cause hair loss? In a minority of patients, yes, and in nearly all of them it grows back. The FDA label lists alopecia at 1 to 10 percent, real-world clinical observation puts noticeable shedding at 5 to 10 percent, and a 2022 systematic review in JAAD International found reported rates from about 3 to 18 percent depending on dose and course length. The mechanism is telogen effluvium, a temporary shift of more follicles than usual into the resting phase, and telogen hairs regrow once the trigger is removed. Permanent loss is not a documented effect of isotretinoin.
Accutane hair loss is shedding, not follicle death. It starts two to three months into treatment, can continue for two to three months after the last dose, and recovers over the following six to twelve months for the large majority.
Why Isotretinoin Causes Shedding
Every scalp hair cycles through anagen, the growth phase of two to six years, a brief catagen, and telogen, a three-month rest at the end of which the hair sheds. Normally 10 to 15 percent of follicles are in telogen at any time. Isotretinoin binds the retinoic acid receptors that regulate cell division in the follicle and pushes a larger share of follicles into rest at once. It also strips the scalp of sebum, and sebum supplies lipid signals the follicle environment depends on. Both effects are dose- and duration-related, and both reverse.
The delay confuses everyone. A follicle that shifts into telogen holds its hair for two to three months before releasing it. Shedding that appears in month three reflects follicles that shifted in month one, and shedding that continues after the course reflects follicles that shifted in the final weeks.
How Common Accutane Hair Loss Is
Reported rates and what raises the risk
FDA prescribing information
1 to 10 percent
Clinical observation, noticeable thinning
5 to 10 percent
2022 JAAD International systematic review
3 to 18 percent depending on protocol
Reddit survey threads, self-reported
Higher, especially among women
What changes the odds
Shorter course
Course longer than six months
No family history of pattern hair loss
Subclinical androgenetic alopecia
Low stress
High stress, which independently extends telogen
Gentle handling, air dry
Tight styles, heat, aggressive brushing
One finding in the review runs against the usual advice. Low dose protocols below 0.5 mg/kg did not show proportionally lower rates of shedding, because course duration turned out to matter more than the daily dose. A patient on 10 mg for 18 months is exposed for three times as long as a patient on 60 mg for six, and the low dose Accutane protocols should not be assumed to protect hair.
When It Starts and How Long It Lasts
Accutane hair loss timeline
Months 1 to 2
Follicles shift into telogen, nothing visible yet
Months 3 to 5
Shedding appears: more hair in the brush, shower and pillow
End of course
Shedding continues or peaks as the last telogen cohort releases
1 to 3 months after
Shedding still present, which surprises patients most
3 to 6 months after
Shed rate normalises, fine new hairs at the temples and hairline
6 to 12 months after
Density returns for most patients
The useful accutane hair loss measurement is the daily shed count. Collecting hairs from the pillow and shower drain on three consecutive mornings and counting them gives a number; more than 150 to 200 a day sustained for four weeks is worth reporting to the prescriber, and under 100 is within normal range even if it feels like more.
Does Accutane Hair Loss Grow Back?
For most patients, fully, within six to twelve months of the last dose, which is the second half of the does accutane cause hair loss question and the more reassuring one. Hair loss after Accutane stops is the tail of the same telogen wave, not new damage, and the new anagen hairs that replace shed ones come in as fine vellus hairs before thickening. The exception is patients with latent androgenetic alopecia, the genetic pattern loss that isotretinoin can unmask by shedding hairs that were already miniaturising. In that group recovery is partial and the pattern that remains is genetic, not drug-related. Thinning still obvious at 9 to 12 months after the course warrants a scalp assessment or trichoscopy, which distinguishes resting follicles that will recover from miniaturising ones that need their own treatment.
What Helps and What Does Not
- 1Biotin does nothing here. Isotretinoin does not deplete biotin, and supplementing a nutrient that is not missing does not shorten telogen. High-dose biotin also interferes with thyroid and troponin lab tests.
- 2Gentle handling helps. Telogen hairs are loosely anchored, so tight ponytails, extensions, daily heat and hard brushing shed hairs early that would have fallen anyway, which makes the loss look worse than it is.
- 3Stress management has a physiological basis. Cortisol extends telogen and delays regrowth, and the anxiety of visible shedding on top of acne is exactly the loop that prolongs it.
- 4Iron, vitamin D and thyroid checks matter for women with heavy shedding, because a second cause of telogen effluvium on top of the drug is common and treatable. These can be added to the Accutane blood work draw.
- 5Minoxidil is an option for patients who want to shorten the recovery, and can be started during the course with the prescriber's agreement.
- 6Dose reduction is the lever if shedding is heavy. Lower dose plus longer course does not always help, so the conversation should be about total exposure.
Dry scalp on Accutane is a separate complaint from hair loss and far more common: the same sebum loss that dries the lips, described in Accutane lips, leaves the scalp flaky and itchy. A gentle sulfate-free shampoo and washing less often fix it, and it does not indicate follicle damage.
In about 5 to 10 percent of patients, with reported rates from 3 to 18 percent depending on the protocol. The drug pushes more follicles than usual into the resting phase, producing shedding from around month three. It is telogen effluvium, not follicle destruction, and the large majority regrow fully after the course.
Shedding typically becomes visible two to three months into treatment, because follicles that shift into rest in month one hold their hair for two to three months before releasing it. It can peak near the end of the course and continue for two to three months after the last dose.
Yes for most patients, over six to twelve months after finishing. Shedding slows three to six months after the last dose and fine new hairs appear at the temples and hairline. Recovery can be partial in patients with underlying genetic pattern hair loss that the drug unmasked, which a scalp assessment can identify.
It can. The 2022 systematic review found that courses below 0.5 mg/kg did not show proportionally less shedding, because course length mattered more than daily dose. A long low dose protocol exposes the follicles for longer, so low dose patients should not assume their hair is protected.
No. Isotretinoin does not deplete biotin, so supplementing it does not shorten the telogen phase or speed regrowth, and high doses interfere with thyroid and cardiac lab tests. Gentle handling, stress control, checking iron, vitamin D and thyroid in heavy shedders, and minoxidil if wanted are the measures with a rationale.
Count shed hairs from the pillow and shower on three consecutive mornings. Under 100 a day is normal range; more than 150 to 200 a day sustained for four weeks is worth reporting. The prescriber can check iron, vitamin D and thyroid and consider a dose reduction if the drug is the main driver.
Accutane.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.
Editorial Team
Comments (0)
Be the first to comment on this article.